$182.6 Million Verdict Against Drug Companies in Las Vegas Hepatitis C Outbreak
After trial: The $182.6 million verdict was made up of $20.1 million in compensatory damages and $162.5 million in punitive damages against Teva, Baxter, and McKesson. Rather than litigate its appeal, Teva agreed in February 2012 to pay roughly $250 to $285 million to settle about 120 remaining Las Vegas hepatitis C lawsuits, though the settlement's allocation to this specific verdict was not disclosed.
Won by Eglet Law.
A Clark County jury awarded five hepatitis C patients $182.6 million against Teva, Baxter Healthcare, and McKesson after finding the companies negligently distributed oversized propofol vials to Las Vegas endoscopy clinics without adequate warnings against multi-patient reuse.
What happened
In 2008, health officials in Southern Nevada traced a hepatitis C outbreak to a group of Las Vegas endoscopy clinics where staff had been reusing propofol vials across multiple patients. The state health division ultimately identified thousands of people who may have been exposed. For a small number of those patients, Robert Sacks, Anne Arnold, James Arnold, Anthony Devito, and Donna Devito, the infections were confirmed, and they turned to the courts.
The plaintiffs sued not the clinics, which had already faced separate legal action, but the pharmaceutical companies that supplied the anesthetic. Their theory was specific: Teva Parenteral Medicines manufactured and sold propofol in 50-milliliter vials at a time when standard outpatient colonoscopy doses ran between 10 and 20 milliliters. Baxter Healthcare and McKesson distributed those vials to the clinics. The companies, the plaintiffs argued, knew smaller single-use vials were appropriate for the setting, yet continued shipping the larger containers without clear warnings against reuse, creating the conditions for cross-contamination.
Robert Eglet and co-counsel Robert Adams tried the case before Judge Ronald Israel. During closing arguments, Eglet described the 50-milliliter containers as 'jumbo vials of infection' and argued that the defendants understood the risk their packaging created. The jury agreed. On October 6, 2011, it found all three companies liable on most claims, not for a defective product itself, but for failing to adequately warn and monitor how their product was being used.
The compensatory phase produced $20.1 million: $8.5 million to Anne Arnold, $5 million each to Sacks and Anthony Devito, $900,000 to James Arnold, and $700,000 to Donna Devito. Punitive damages, awarded four days later on October 10, added another $162.5 million. Teva bore the largest share at $89.4 million, followed by Baxter at $55.3 million and McKesson at $17.9 million. The combined total came to $182.6 million. Teva stated it would appeal.
Sources
This account is drawn from contemporaneous public reporting and the court record.
- 1.Las Vegas Sun: Jury finds drug firms liable in Vegas hepatitis C case, Oct. 6, 2011·Archived copy
- 2.Las Vegas Sun: Drug firms told to pay $162 million in punitive damages, Oct. 10, 2011·Archived copy
- 3.Las Vegas Review-Journal: Drug companies found liable in hepatitis C infections, 2011·Archived copy
- 4.ABC11 (AP wire): Jury finds drug firms liable in Vegas hepatitis C case, Oct. 6, 2011·Archived copy
More proven verdicts from Eglet Law
All Eglet Law proven verdicts →A Clark County jury awarded $3.8 billion against Real Water on March 21, 2025, after finding the Las Vegas alkaline water company liable for poisoning consumers with hydrazine-contaminated product that caused acute liver failure, autoimmune disease, and death.
Retained as outside counsel to the Nevada Attorney General, Eglet Adams drove more than $1.1 billion in opioid settlements across 12 agreements with over 40 defendants, including Walgreens, McKesson, AmerisourceBergen, Cardinal Health, and Johnson & Johnson.
An $800 million settlement from MGM Resorts International resolved claims by more than 4,400 plaintiffs over the October 1, 2017 Route 91 Harvest Festival mass shooting in Las Vegas, one of the largest victim-compensation settlements in U.S. history.
A Clark County jury awarded Henry and Lorraine Chanin $505 million against Teva Parenteral Medicines and Baxter Healthcare after finding that both companies supplied oversized propofol vials to Las Vegas endoscopy clinics, enabling the reuse that infected Henry Chanin with hepatitis C.
Related product liability verdicts
Sullivan Papain was among the firms representing New York State against Philip Morris, R.J. Reynolds, Brown & Williamson, and Lorillard, securing a $25 billion recovery through the 1998 Master Settlement Agreement.
C. Steven Yerrid, the youngest of Florida's 11-lawyer 'Dream Team,' added racketeering and conspiracy charges that tripled the damages ceiling, helping the state secure what was then the largest civil settlement in American history against the tobacco industry.
As co-lead counsel in the federal Roundup multidistrict litigation and the first firm to sue Monsanto in 2015, Weitz and Luxenberg helped negotiate a $10.9 billion settlement resolving approximately 125,000 non-Hodgkin lymphoma claims against Bayer-owned Monsanto.
After fifteen years of litigation and three failed bankruptcy maneuvers by Johnson and Johnson subsidiaries, Ashcraft and Gerel attorneys R. Bryant McCulley and Michelle Parfitt helped negotiate a global, uncapped settlement of at least $5.5 billion covering approximately 76,000 ovarian-cancer claims.